Frequencies for first 10,000 rows of drug6cl1 variable in nhamcsed2003 dataset : drug class #1 for medication #6 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, general | 1 0.01 0.01 adjuncts to anesthesia/analeptics | 8 0.08 0.09 antidotes, specific | 2 0.02 0.11 antidotes, general | 1 0.01 0.12 penicillins | 2 0.02 0.14 cephalosporins | 16 0.16 0.30 erythromycins/lincosamides/macrolides | 3 0.03 0.33 tetracyclines | 1 0.01 0.34 sulfonamides and trimethoprim | 2 0.02 0.36 miscellaneous antibacterial agents | 6 0.06 0.42 quinolones/derivatives | 3 0.03 0.45 antiviral agents | 1 0.01 0.46 deficiency anemias | 3 0.03 0.49 anticoagulants/thrombolytics | 14 0.14 0.63 cardiac glycosides | 6 0.06 0.69 antiarrhythmic agents | 1 0.01 0.70 antianginal agents | 10 0.10 0.80 vascular disorders, cerebral/peripheral | 2 0.02 0.82 agents used to treat shock/hypotension | 1 0.01 0.83 antihypertensive agents | 7 0.07 0.90 diuretics | 18 0.18 1.08 calcium channel blockers | 7 0.07 1.15 beta blockers | 14 0.14 1.29 alpha agonist/alpha blockers | 8 0.08 1.37 ace inhibitors | 10 0.10 1.47 sedatives and hypnotics | 28 0.28 1.75 antianxiety agents | 22 0.22 1.97 antipsychotic/antimanics | 6 0.06 2.03 antidepressants | 23 0.23 2.26 cns, miscellaneous | 1 0.01 2.27 antiemetics | 2 0.02 2.29 diagnostics, radiopaque & nonradioactiv | 2 0.02 2.31 disorders, acid/peptic | 19 0.19 2.50 antidiarrheals | 1 0.01 2.51 laxatives | 7 0.07 2.58 miscellaneous gastrointestinals | 2 0.02 2.60 antispasmodics/anticholinergics | 1 0.01 2.61 antacids | 2 0.02 2.63 hyperlipidemia | 11 0.11 2.74 vitamins/minerals | 6 0.06 2.80 nutrition, enteral/parenteral | 3 0.03 2.83 repl/regs of electrolytes/water balance | 30 0.30 3.13 adrenal corticosteroids | 4 0.04 3.17 estrogens/progestins | 1 0.01 3.18 anterior pituitary/hypothalamic functio | 1 0.01 3.19 blood glucose regulators | 12 0.12 3.31 thyroid/antithyroid | 1 0.01 3.32 vaccines/antisera | 4 0.04 3.36 immunomodulators | 1 0.01 3.37 antiseptics/disinfectants | 2 0.02 3.39 dermatologics, misc. | 3 0.03 3.42 topical steroids | 2 0.02 3.44 acne products | 1 0.01 3.45 topical anti-infectives | 1 0.01 3.46 skeletal muscle hyperactivity | 10 0.10 3.56 anticonvulsants | 14 0.14 3.70 antineoplastics, miscellaneous | 1 0.01 3.71 hormonal/biological response mod. | 1 0.01 3.72 glaucoma | 2 0.02 3.74 otic, topical (misc) | 1 0.01 3.75 vertigo/motion sickness/vomiting | 6 0.06 3.81 analgesics/general | 3 0.03 3.84 analgesics, narcotic | 43 0.43 4.27 analgesics, non-narcotic | 26 0.26 4.53 antimigraine/other headaches | 1 0.01 4.54 antiarthritics | 8 0.08 4.62 antigout | 1 0.01 4.63 nsaid | 20 0.20 4.83 antiprotozoals | 1 0.01 4.84 antimalarials | 2 0.02 4.86 antiasthmatics/bronchodilators | 24 0.24 5.10 nasal decongestants | 1 0.01 5.11 antitussives/expectorants/mucolytics | 5 0.05 5.16 antihistamines | 7 0.07 5.23 unclassified | 20 0.20 5.43 . | 9,457 94.57 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016